within Pharmacolibrary.Drugs.ATC.B;

model B05XA18
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 0.16 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Zinc sulfate is an inorganic compound and a dietary supplement used to treat and prevent zinc deficiency. It is also used as an adjunct in oral rehydration therapy in children with diarrhea and in other medical conditions associated with zinc depletion. It is approved for medical use today and is included in the World Health Organization's List of Essential Medicines.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult population based on limited published data for oral zinc formulations, as no direct popPK or clinical PK study for zinc sulfate with model parameters (Vd, Cl, ka) was identified.</p><h4>References</h4><ol><li><p>Ding, Y, et al., &amp; Wen, AD (2012). The effect of staggered administration of zinc sulfate on the pharmacokinetics of oral cephalexin. <i>British journal of clinical pharmacology</i> 73(3) 422–427. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.2011.04098.x&quot;>10.1111/j.1365-2125.2011.04098.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22023069/&quot;>https://pubmed.ncbi.nlm.nih.gov/22023069</a></p></li><li><p>Zhang, SQ, et al., &amp; Zhang, Y (2018). Comparison of the Oral Absorption, Distribution, Excretion, and Bioavailability of Zinc Sulfate, Zinc Gluconate, and Zinc-Enriched Yeast in Rats. <i>Molecular nutrition &amp; food research</i> 62(7) e1700981–None. DOI:<a href=&quot;https://doi.org/10.1002/mnfr.201700981&quot;>10.1002/mnfr.201700981</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29457347/&quot;>https://pubmed.ncbi.nlm.nih.gov/29457347</a></p></li><li><p>Sparsa, A, &amp; Bonnetblanc, JM (2004). [Lithium]. <i>Annales de dermatologie et de venereologie</i> 131(3) 255–261. DOI:<a href=&quot;https://doi.org/10.1016/s0151-9638(04)93588-0&quot;>10.1016/s0151-9638(04)93588-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15107743/&quot;>https://pubmed.ncbi.nlm.nih.gov/15107743</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B05XA18;
